clinical trial · NCT02567188
A Study of MIRCERA in Participants With Chronic Kidney Disease Stage 3-4 and Not on Dialysis
Hoffmann-La Roche·—·completed·n = 144
AnemiaMIRCERA
brief summary
An observational, longitudinal, multi-center, non-interventional study in participants with chronic kidney disease (CKD) stage 3-4, assessed by Modification of Diet in Renal Disease (MDRD) to collect data regarding safety and efficacy in participants with pre-dialysis situation who are treated with MIRCERA in normal clinical environment.
started
Apr 1, 2009
primary completion
Apr 1, 2011
completion
Apr 1, 2011
last updated
Sep 11, 2025
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol